Sales soar for Roche's OTC anti-obesity drug

12/5/2005 | Stuff (New Zealand)

Sales of Roche Holding's anti-obesity drug Xenical have risen 90% in New Zealand since it was made available without prescription six months ago, but a women's group says ads for the drug target people who do not need it. A Roche spokesman said the average size of a person taking Xenical has fallen from a body mass index of 36 to 34 since the drug was given OTC status.

View Full Article in:

Stuff (New Zealand)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT